Literature DB >> 9138307

Clinical significance of three-dimensional helical CT in neurosurgery.

J Tacke1, H M Klein, H Bertalanffy, L Mayfrank, A Thron, J M Gilsbach, R W Günther.   

Abstract

The authors report about a 3-years experience with helical CT and 3-D surface reconstruction applied in neurosurgical patients. All examinations were performed in addition to preexisting diagnostic CT, MRI, or angiography. The aim of this study was to assess the clinical value of this method with regard to planning of the surgical approach to anterior, middle, and posterior skull base and spinal lesions. 75 examinations of 55 patients were analysed and ranked as follows: A = examination with significant additional information for neurosurgical planning of skull base or spinal procedures or for postoperative evaluation of the neurosurgical approach, B = examination with some useful information for the neurosurgical planning or postoperative control, however, without significant advantage as compared to established diagnostic methods, C = examination without significant additional information. Classification was performed independently by two experienced surgeons. Examinations of anterior, middle, and posterior skull base lesions including cerebral aneurysms were in the majority rated as helpful and significantly informative, (A = 21, B = 24, C = 9, n = 54). Three-dimensional imaging of the spine was of clinical value only in specific cases (A = 6, B = 6, C = 9, n = 21). The authors conclude that three-dimensional imaging is a valuable diagnostic tool for pre- and postoperative imaging of tumorous and vascular lesions adjacent to the skull base, allowing for optimal surgical approaches with minimal invasiveness.

Entities:  

Mesh:

Year:  1997        PMID: 9138307     DOI: 10.1055/s-2008-1053411

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  1 in total

1.  Intravenous 3D digital subtraction angiography in the diagnosis of unruptured intracranial aneurysms.

Authors:  S Toyota; K Iwaisako; H Takimoto; T Yoshimine
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.